Related Experiment Video
Updated: Jan 9, 2026
12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
3.8K
Chrysoeriol Exerts Antiplatelet Effects by Regulating cAMP/cGMP and PI3K/MAPK Pathway
Ga Hee Lee1, Jin Pyo Lee1, Akram Abdul Wahab2
1Department of Biomedical Laboratory Science, Namseoul University, Cheonan 31020, Republic of Korea.
Biomolecules & Therapeutics
|December 1, 2025
Summary
Chrysoeriol, a flavonoid, effectively inhibits platelet aggregation by modulating cyclic nucleotides and kinase pathways. This natural compound shows potential for preventing thrombotic cardiovascular events.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiovascular Research
Background:
- Chrysoeriol, a flavonoid from traditional herbs, possesses anti-inflammatory and antioxidant properties.
- Its potential antiplatelet activity suggests a role in preventing cardiovascular diseases.
Purpose of the Study:
- To elucidate the molecular mechanisms behind chrysoeriol's antiplatelet effects.
- Investigate chrysoeriol's impact on platelet activation pathways.
Main Methods:
- Assessed collagen-induced platelet aggregation and cytotoxicity.
- Measured intracellular cyclic AMP (cAMP) and cyclic GMP (cGMP) levels.
- Analyzed phosphorylation of IP3R, PI3K, Akt, JNK, p38 MAPK, and calcium mobilization.
Main Results:
- Chrysoeriol suppressed platelet aggregation without cytotoxicity.
- Elevated cAMP/cGMP, enhanced IP3R phosphorylation, and reduced Ca2+ mobilization.
- Inhibited PI3K/Akt/JNK/p38 MAPK pathways, decreasing cPLA2 and TXA2 production.
- Reduced thromboxane A2 (TXA2) secretion and dense granule release (ATP, serotonin).
- Impaired thrombin-induced clot retraction.
Conclusions:
- Chrysoeriol exhibits multi-target antiplatelet mechanisms.
- Modulates cyclic nucleotides, kinase signaling, and platelet function.
- Potential therapeutic agent for preventing thrombotic cardiovascular events.
Related Concept Videos
01:25cAMP-dependent Protein Kinase Pathways
8.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.2K
01:09GPCRs Regulate Adenylyl Cylase Activity
7.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
01:11IP3/DAG Signaling Pathway
14.2K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
14.2K
01:16Calmodulin-dependent Signaling
6.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.0K
01:22Amplifying Signals via Enzymatic Cascade
17.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.0K